<DOC>
	<DOCNO>NCT00566124</DOCNO>
	<brief_summary>To purpose study compare pharmacodynamic property insulin detemir , insulin glargine NPH insulin single subcutaneous injection .</brief_summary>
	<brief_title>Basal Insulins - Pharmacodynamics</brief_title>
	<detailed_description>In randomize , double-blind , euglycemic glucose clamp study , 10 healthy male volunteer receive subcutaneous injection 0.4 U/kg insulin detemir , insulin glargine NPH insulin three separate study day cross-over design . After insulin administration , plasma glucose maintain 0.3 mmol/l fast level 24 hour manually adjust glucose infusion . C-peptide , insulin , NEFA counter regulatory hormone measure throughout clamp period . Endogenous glucose release ( EGR ) assess isotope dilution technique ( 3-3H-glucose ) .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Male BMI 20 50 kg/m2 Blood pressure &lt; 140/90 mmHg sign informed consent Caucasien Diabetes disease Alcohol drug abuse Smoking Use prescription drug</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Levemir , Lantus , Insulatard , Pharmacodynamics , Healthy human</keyword>
</DOC>